Episode 122: NCI Director Shares Research and Innovation During COVID-19

Norman “Ned” Sharpless, MD, director of the National Cancer Institute (NCI), joins Lisa Kennedy Sheldon, PhD, ANP-BC, AOCNP®, FAAN, ONS’s clinical and scientific affairs liaison, to discuss NCI’s COVID-19 coronavirus research efforts, how the agency is partnering with oncology nurses to understand the best care for patients with COVID-19 and cancer, nursing innovation during the pandemic, and the implications of delayed screening and care on future cancer incidence rates.    Music Credit: "Fireflies and Stardust" by Kevin MacLeod   Licensed under Creative Commons by Attribution 3.0  Episode Notes   Check out these resources related to today’s episode:    The NCPD activity for this episode has expired, but you can still earn NCPD through many other Oncology Nursing Podcast episodes. Find a full list of opportunities.  Oncology Nursing Podcast Episode 106: NINR Director Discusses Nursing Research Amid COVID-19   ONS Voice article: Federal Agencies Collaborate; Nurse Proposes Healthcare Bill; NCI Shifts Research to COVID-19   ONS Voice article: NCI Cancer Research Persists Despite COVID-19 Limitations    ONS Recommendations for Oncology Staff Assignments During the COVID-19 Pandemic   ONS Interim Guidelines During the COVID-19 Pandemic   Dr. Sharpless’s Science Editorial on COVID-19 and Cancer  Childhood Cancer Data Initiative (CCDI)  The NCI Bottom Line Blog  NCI Community Oncology Research Program (NCORP)  NCI COVID-19 in Cancer Patients Study   NCI’s COVID-19 Information for Cancer Researchers   NCI-MATCH Trial